BBlogFlow

Saskatchewan could see severe cold and flu season: Expert - paNOW

·2d ago

This story deserves to be shared

Send it to someone who'd care, or post it on your networks.

Facebook Twitter Email

“Of course, we’re now scrambling to try and get as many people immunized as we can, just in anticipation that this virus was already here.”

Dr. Blondeau strongly encourages people to get vaccinated. Cold and fluThe virus linked to the common cold is also circulating. “Rhinovirus is the number one cause of the common cold, and we know it’s quite prevalent,” he explained. “Based on the specimens tested in the laboratory, positivity rates are exceeding 30 per cent.”Dr. Blondeau said people have begun to notice symptoms at home, work and school. “A lot of people have been feeling unwell, a little cough, achy, maybe some sniffles and whatnot, and right now we’re seeing a tremendous amount of rhinovirus circulating.”He warned against lumping cold and flu symptoms together because they often overlap. Questions about the vaccineWhen it comes to what goes into a flu vaccine, Dr. Blondeau said it changes annually to help scientists stay ahead of the curve. “There are sentinel laboratories around the world, including here in Canada. When we have a positive influenza specimen, we can forward that off to the National Microbiology Laboratory.

This article is an excerpt. To read the full content, visit the original source. paNOW

Reactions

0 comments

No comments yet. Be the first to share your thoughts!

Facebook Twitter

Related articles

Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.

Medical Xpress·

Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily

“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.

Oncodaily·